Unrecognized Tax Benefits of BridgeBio Oncology Therapeutics, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of unrecognized tax benefits.
Summary: BridgeBio Oncology Therapeutics, Inc. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
BridgeBio Oncology Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $2,164,000, a 65% increase year-over-year.
Source SEC data: View on sec.gov

Unrecognized Tax Benefits, Quarterly (USD)

Unrecognized Tax Benefits, YoY Quarterly Change (%)

BridgeBio Oncology Therapeutics, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$2,164,000	+$851,000	+65%	31 Dec 2025	10-K	05 Mar 2026	2025	FY
Q4 2024	$1,313,000	+$871,000	+197%	31 Dec 2024	10-K	05 Mar 2026	2025	FY
Q4 2023	$442,000			31 Dec 2023	10-K	05 Mar 2026	2025	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.